(PharmaNewsWire.Com, January 06, 2017 ) According to the report Immunotherapy Drugs, published by Market Data Forecast, the global market is projected to reach USD 112.69 Billion by 2021, at a CAGR of 10.5% from 2016 to 2021.
The usage of the immunotherapy drugs is rising with increasing cancer incidences and autoimmune diseases and is estimated to witness a positive outlook in the forecast period. Immunotherapy is a process of enhancing your innate power of the immune system to fight against cancer cells. It either counteract the signal which are produced by the cancer cells and suppress the responses by immune system or stimulate the specific components of immune system. These properties of the immunotherapies make them to treat diseases involving infection, cancer, respiratory and autoimmune disorders.
With the evolution of innovation and technology, increasing prevalence of cancer and auto immune diseases, immunotherapy drugs are expected to gain significance in the future. Some other driving factors for the immunotherapy drugs includes rising incidences of diseases, higher efficiency than the common drugs, acceleration in the development and review of new drugs. However, the market is dampened by the high costs involving immunotherapy drugs and limited access to the lower and middle-income groups.
Immunotherapy Drug Market is segmented as following.
Based on Type: Monoclonal Antibodies Interferons Interleukins Vaccines Checkpoint Inhibitors Based on Application: Blood Cancer Cervical Cancer Breast Cancer Glioblastoma Lung Cancer Gastric Cancer Prostate Cancer Melanoma Geographical Segmentation: North America Immunotherapy Drug Market Europe Immunotherapy Drug Market Asia-Pacific Immunotherapy Drug Market Latin America Immunotherapy Drug Market Middle-East & Africa Immunotherapy Drug Market
The major companies operating in the Immunotherapy Drugs market include Merck (U.S), Roche (Switzerland), Eli Lilly (U.S.), Amgen (U.S.), Novartis (Switzerland), Celgene (U.S.), AstraZeneca (U.K.), Bristol Myers Squibb (U.S.), GlaxoSmithKline PLC (U.K.) and Seattle Genetics (U.S.).
The Immunotherapy Drugs Market study offers the following deliverables:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in Pharmaceuticals Segment:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
